|Day Low/High||5.43 / 5.54|
|52 Wk Low/High||3.91 / 9.20|
Two out of the five shareholder groups involved in the litigation say they will accept the settlement offer.
A production cut pushes beleaguered producers and services firms higher.
Brexit and the U.S. election have introduced far more uncertainty than previously assumed.
Royal Bank of Scotland's stress-test failure marks another twist in a long and winding road to recovery for the beleaguered lender.
European stocks extended gains Wednesday as OPEC ministers near an agreement on production limits at their summit in Vienna.
RBS misses both key targets in Bank of England tests, says it must "do more" to restore resilience.
The U.K. government has reduced its stake in rescued lender Lloyds Banking Group to less than 8%
The ABN share sale follows a strong third quarter and highlights the diverging fortunes between Dutch and U.K. taxpayers.
RBS has tied up with Iwoca and other alternative lenders to refer customers.
Britain's majority state-owned bank faces a fine of anywhere between $5 billion and $12 billion, according to official in charge of the government's bank bailout holdings.
Speculation about regulatory action from the European Commission shows the litigation threat is alive and well.
The prospect of a trade spat with China puts HSBC in the spotlight as Deutsche Bank wilts on regulation worries.
Investors should keep an eye on French stocks, despite a reputation for bureaucracy.
RBS will set aside nearly $500 million to cover costs associated with an FCA investigation into SME clients fees.
The grocer's banking subsidiary freezes online current accounts after deposits are plundered.
The banking company offers a strong financial scorecard, a hefty dividend and resolved legacy challenges.
A partial victory for Brexit opposition and mixed corporate earnings drive markets in Europe.
The pound surges to a one-month high after a U.K. ruling deals a hammer blow to the government's Brexit ambitions.
Steep losses for oil, earnings aftershocks and another Clinton investigation leave markets reeling.
Economic data in France disappoints; Germany and U.K. beat expectations.
From DoJ fines to shareholder litigation, short-term noise is obscuring a strengthening core franchise.
Pharma group Sanofi rises on improved guidance and RBS gains after a third-quarter profit beat.
Shares in the lender rise more than 4% in early trading.
But the U.K. lender stands by its financial targets and reports better-than-expected capital generation in the third quarter.
The U.K. currency falls to its lowest intra-day level since the Oct. 7 'flash crash' before testimony from Bank of England Governor Mark Carney.
Shareholders will also strain for information on the post-Brexit outlook at the Edinburgh lender.
Shares in the sector fall on the prospect of more uncertainty for Deutsche Bank and others.